Generic Pharmaceuticals
Active 2007–2026. The register lists this client once for every firm that files on its behalf; all 4 of its records are shown together here.
| Year | Firm | Period | Amount | Doc |
|---|---|---|---|---|
| 2026 | GOVERNMENT COUNSEL, LLC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$30,000 | |
| 2026 | GOVERNMENT COUNSEL, LLC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$30,000 | |
| 2026 | GOVERNMENT COUNSEL, LLC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$20,000 | |
| 2025 | GOVERNMENT COUNSEL, LLC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$20,000 | |
| 2025 | GOVERNMENT COUNSEL, LLC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$20,000 | |
| 2025 | GOVERNMENT COUNSEL, LLC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$20,000 | |
| 2025 | GOVERNMENT COUNSEL, LLC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$20,000 | |
| 2024 | GOVERNMENT COUNSEL, LLC |
4th Quarter (Oct 1 - Dec 31) AMENDED |
$20,000 | |
| 2024 | GOVERNMENT COUNSEL, LLC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$20,000 | |
| 2024 | GOVERNMENT COUNSEL, LLC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$20,000 |
| Firm | Filings | Amount |
|---|---|---|
| BROWN RUDNICK LLP | 50 | $2,040,000 |
| GOVERNMENT COUNSEL, LLC | 33 | $1,250,000 |
| DOW LOHNES GOVERNMENT STRATEGIES LLC | 6 | $110,000 |
| GILBERT'S LLP | 7 | — |
| Issue | Activities |
|---|---|
| Health Issues | 67 |
| Copyright/Patent/Trademark | 17 |
| Manufacturing | 16 |
| Pharmacy | 15 |
| Budget/Appropriations | 10 |
| Medicare/Medicaid | 7 |
| Defense | 4 |
| Taxation/Internal Revenue Code | 2 |
| Trade (domestic/foreign) | 2 |